Ambenonium chloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ambenonium chloride and what is the scope of patent protection?
Ambenonium chloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for ambenonium chloride
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Patent Applications: | 629 |
| DailyMed Link: | ambenonium chloride at DailyMed |
Medical Subject Heading (MeSH) Categories for ambenonium chloride
Anatomical Therapeutic Chemical (ATC) Classes for ambenonium chloride
US Patents and Regulatory Information for ambenonium chloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | MYTELASE | ambenonium chloride | TABLET;ORAL | 010155-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
